h-d-phe-pip-arg-pna has been researched along with bucladesine in 1 studies
Studies (h-d-phe-pip-arg-pna) | Trials (h-d-phe-pip-arg-pna) | Recent Studies (post-2010) (h-d-phe-pip-arg-pna) | Studies (bucladesine) | Trials (bucladesine) | Recent Studies (post-2010) (bucladesine) |
---|---|---|---|---|---|
95 | 1 | 5 | 9,775 | 13 | 210 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arcone, R; Chinali, A; Gast, A; Grimaldi, M; Pagliuca, MG; Pietropaolo, C; Schettini, G | 1 |
1 other study(ies) available for h-d-phe-pip-arg-pna and bucladesine
Article | Year |
---|---|
Thrombin mutants with altered enzymatic activity have an impaired mitogenic effect on mouse fibroblasts and are inefficient modulators of stellation of rat cortical astrocytes.
Topics: 3T3 Cells; Animals; Astrocytes; Blood Coagulation; Bucladesine; Cell Differentiation; Cells, Cultured; Chromogenic Compounds; Dipeptides; DNA, Complementary; Endopeptidases; Enzyme Activation; Enzyme Precursors; Mice; Microscopy, Phase-Contrast; Mitogens; Point Mutation; Prothrombin; Rats; Rats, Wistar; Receptors, Thrombin; Reverse Transcriptase Polymerase Chain Reaction; Thrombin | 1999 |